GlassScriptPhysician profile
Jordan P Allem
NPI 1255567830
$3,728.47
in general payments reported to CMS, 2019-2025
41 companies · $436 in 2025
The $436 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $500 · 2020: $143 · 2021: $598 · 2022: $626 · 2023: $792 · 2024: $634 · 2025: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,861.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $384.61 | 2019-2025 | Lux-Dx Insertable Cardiac Monitor, General - Brady |
| Novartis Pharmaceuticals Corporation | $302.21 | 2019-2025 | |
| Pfizer INC. | $257.87 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $246.68 | 2021-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $207.77 | 2019-2023 | Lifevest |
| Irhythm Technologies, INC. | $174.38 | 2020-2024 | Zio Xt Patch, Zio Monitor |
| Medtronic, INC. | $148.92 | 2021-2025 | Linq II |
| Takeda Pharmaceuticals U.S.A., INC. | $145.99 | 2021-2025 | Entyvio |
| Kiniksa Pharmaceuticals, LTD. | $139.29 | 2022-2023 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $131.38 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $120.22 | 2022-2023 | Verquvo |
| Janssen Pharmaceuticals, INC | $112.95 | 2019-2020 | |
| Amgen INC. | $112.77 | 2019-2025 | Repatha, Evenity, Prolia |
| Daiichi Sankyo INC. | $111.71 | 2021-2023 | Injectafer |
| Baxter Healthcare | $105.39 | 2023-2024 | Hillrom - Cardiac Ambulatory Monitor |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Allem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.